Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Judith Stephenson Department of
Sexually Transmitted Disease, University College London Medical School,
London WC1 6AU
Correspondence to: Dr Stephenson jstephen@gum.ucl.ac.uk
The first 150 words of the full text of this article appear below.
The value of the randomised controlled trial still
generates debate.1 Although some of the earliest examples
of these trials can be found in behavioural and psychosocial
research, this is not an area that has adopted readily the randomised
controlled trial to assess interventions.2 Two recent
developments have intensified debate about the role of randomised
controlled trials
the urgent need to find effective behavioural
interventions against HIV
3 4
and the advance of evidence
based medicine, which is moving the randomised controlled trial beyond
clinical trials into areas such as health promotion. This article
considers the merits and limitations of randomised controlled trials in
the behavioural area compared with clinical medicine, and asks how these trials can be applied successfully to assess behavioural interventions.
| |
Merits and limitations |
|---|
The merits and limitations of randomised controlled trials
in general have been widely discussed
5 6
; only key points are repeated here. In clinical medicine, the randomised controlled trial is
What can you learn from this BMJ paper? Read Leanne Tite's Paper+